Tugwell P - Search Results

1

Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.

Wolfe F, Lassere M, van der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, Eberhardt K, Kvien TK, Symmons D, Silman A, van Riel P, Tugwell P, Boers M. Wolfe F, et al. Among authors: tugwell p. J Rheumatol. 1999 Feb;26(2):484-9. J Rheumatol. 1999. PMID: 9972992

2

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS. Wells GA, et al. Among authors: tugwell ps. J Rheumatol. 2005 Oct;32(10):2016-24. J Rheumatol. 2005. PMID: 16206362

3

It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.

Strand V, Boers M, Idzerda L, Kirwan JR, Kvien TK, Tugwell PS, Dougados M. Strand V, et al. J Rheumatol. 2011 Aug;38(8):1720-7. doi: 10.3899/jrheum.110392. J Rheumatol. 2011. PMID: 21807792

4

Assessing the activity of rheumatoid arthritis.

Boers M, van Riel PL, Felson DT, Tugwell P. Boers M, et al. Among authors: tugwell p. Baillieres Clin Rheumatol. 1995 May;9(2):305-17. doi: 10.1016/s0950-3579(05)80192-x. Baillieres Clin Rheumatol. 1995. PMID: 7656342 Review.

5

OMERACT conference questionnaire results. OMERACT Committee.

Boers M, Tugwell P. Boers M, et al. Among authors: tugwell p. J Rheumatol. 1993 Mar;20(3):552-4. J Rheumatol. 1993. PMID: 8478871 Review.

6

Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee.

Tugwell P, Boers M. Tugwell P, et al. J Rheumatol. 1993 Mar;20(3):555-6. J Rheumatol. 1993. PMID: 8478872 Review. No abstract available.

7

The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.

Boers M, Tugwell P. Boers M, et al. Among authors: tugwell p. J Rheumatol. 1993 Mar;20(3):568-74. J Rheumatol. 1993. PMID: 8478876

8

The OMERACT filter for Outcome Measures in Rheumatology.

Boers M, Brooks P, Strand CV, Tugwell P. Boers M, et al. Among authors: tugwell p. J Rheumatol. 1998 Feb;25(2):198-9. J Rheumatol. 1998. PMID: 9489805 No abstract available.

9

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, Gordon C, Isenberg DA, Klippel JH, Petri M, Simon L, Tugwell P, Wolfe F. Smolen JS, et al. Among authors: tugwell p. J Rheumatol. 1999 Feb;26(2):504-7. J Rheumatol. 1999. PMID: 9972996

10

Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.

Lassere MN, Johnson KR, Boers M, Carlton K, Day RO, de Wit M, Edwards IR, Fries JF, Furst DE, Kirwan JR, Tugwell PS, Woodworth TG, Brooks PM. Lassere MN, et al. J Rheumatol. 2005 Oct;32(10):2037-41. J Rheumatol. 2005. PMID: 16206366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,080 results

Search Page

Filters